Related Experiment Video
Updated: May 27, 2026

The Rabbit Model of Accelerated Atherosclerosis: A Methodological Perspective of the Iliac Artery Balloon Injury
Published on: October 3, 2017
An integrated approach for the mechanisms responsible for atherosclerotic plaque regression
Andrew A Francis1, Grant N Pierce
1Institute of Cardiovascular Sciences, St Boniface Hospital Research Centre, Department of Physiology, Faculties of Medicine and Pharmacy, University of Manitoba, Winnipeg, Manitoba.
Insights
Atherosclerotic plaque regression involves lipid removal, endothelial repair, and smooth muscle cell normalization. Understanding these dynamic processes is key for developing targeted pharmaceutical therapies to combat atherosclerosis.
Area of Science:
- Cardiovascular Biology
- Pathology
- Translational Medicine
Background:
- Atherosclerosis, once viewed as age-related, involves dynamic plaques capable of regression.
- High-density lipoprotein (HDL) is studied for its role in plaque regression, but regression is multifactorial.
- Plaque regression involves complex cellular and molecular processes beyond lipid removal.
Purpose of the Study:
- To provide a comprehensive overview of atherosclerotic plaque regression.
- To integrate current knowledge on the diverse mechanisms driving plaque regression.
- To highlight the importance of an integrated view for pharmaceutical targeting.
Main Methods:
- Literature review and synthesis of existing research on plaque regression mechanisms.
- Categorization of regression processes into lipid removal, endothelial repair, and smooth muscle cell modulation.
- Integration of findings to present a holistic model of plaque regression.
Main Results:
- Plaque regression involves active removal of lipids and necrotic debris via macrophage migration to lymph nodes.
- Endothelial function restoration occurs through proliferation of neighboring cells and circulating endothelial progenitor cells.
- Vascular smooth muscle cell proliferation cessation is a secondary consequence of improved milieu and repair processes.
Conclusions:
- Atherosclerotic plaque regression is a multifaceted process involving coordinated cellular responses.
- An integrated understanding of plaque regression pathways is crucial for effective pharmaceutical intervention.
- Targeting multiple regression mechanisms offers a promising strategy for treating atherosclerosis.
Abstract:
Atherosclerosis was originally considered to be an ongoing process that was inevitably associated with age. However, plaques are highly dynamic, and are able to progress, stabilize or regress depending on their surrounding milieu. A great deal of research attention has been focused on understanding the involvement of high-density lipoprotein in atherosclerotic plaque regression. However, atherosclerotic plaque regression encompasses a variety of processes that can be grouped into three main areas: removal of lipids and necrotic material; restoration of endothelial function and repair of denuded areas; and cessation of vascular smooth muscle cell proliferation and phenotype reversal. In addition to the role of high-density lipoproteins in lipid removal, resident macrophages and foam cells are able to regain motility and rapidly migrate on milieu improvement, moving both lipids and necrotic material to regional lymph nodes. Neighbouring endothelial cells can proliferate and replace dead and dysfunctional cells. Circulating endothelial progenitor cells can similarly restore vessel function. Finally, abrogation of smooth muscle cell proliferation occurs secondarily to these processes. This information is integrated in the current article to present a comprehensive and clear depiction of plaque regression. This integrated view of regression is essential to optimize the pharmaceutical targeting of the many processes and pathways involved in plaque regression.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease II: Pathophysiology
Inflammation
Atherosclerosis IV: Nursing Management
